Φορτώνει......
Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy
Tumour infiltration by regulatory T (Treg) cells contributes to suppression of the anti‐tumour immune response, which limits the efficacy of immune‐mediated cancer therapies. The phosphoinositide 3‐kinase (PI3K) pathway has key roles in mediating the function of many immune cell subsets, including T...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Immunology |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587315/ https://ncbi.nlm.nih.gov/pubmed/31107985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13082 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|